IBDEI0N4 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10402,0)
 ;;=96160^^40^442^4^^^^1
 ;;^UTILITY(U,$J,358.3,10402,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10402,1,2,0)
 ;;=2^HLTH RISK ASSESSMENT,PT FOCUSED
 ;;^UTILITY(U,$J,358.3,10402,1,3,0)
 ;;=3^96160
 ;;^UTILITY(U,$J,358.3,10403,0)
 ;;=96161^^40^442^3^^^^1
 ;;^UTILITY(U,$J,358.3,10403,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10403,1,2,0)
 ;;=2^HLTH RISK ASSESSMENT,CAREGIVR FOCUSED
 ;;^UTILITY(U,$J,358.3,10403,1,3,0)
 ;;=3^96161
 ;;^UTILITY(U,$J,358.3,10404,0)
 ;;=96110^^40^442^2^^^^1
 ;;^UTILITY(U,$J,358.3,10404,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10404,1,2,0)
 ;;=2^DEVELOPMENTAL SCREEN W/ SCORE
 ;;^UTILITY(U,$J,358.3,10404,1,3,0)
 ;;=3^96110
 ;;^UTILITY(U,$J,358.3,10405,0)
 ;;=96127^^40^442^1^^^^1
 ;;^UTILITY(U,$J,358.3,10405,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10405,1,2,0)
 ;;=2^BRIEF EMOTIONAL/BEHAV ASSESSMENT
 ;;^UTILITY(U,$J,358.3,10405,1,3,0)
 ;;=3^96127
 ;;^UTILITY(U,$J,358.3,10406,0)
 ;;=86485^^40^443^1^^^^1
 ;;^UTILITY(U,$J,358.3,10406,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10406,1,2,0)
 ;;=2^CANDIDA
 ;;^UTILITY(U,$J,358.3,10406,1,3,0)
 ;;=3^86485
 ;;^UTILITY(U,$J,358.3,10407,0)
 ;;=86486^^40^443^4^^^^1
 ;;^UTILITY(U,$J,358.3,10407,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10407,1,2,0)
 ;;=2^MUMPS
 ;;^UTILITY(U,$J,358.3,10407,1,3,0)
 ;;=3^86486
 ;;^UTILITY(U,$J,358.3,10408,0)
 ;;=86580^^40^443^5^^^^1
 ;;^UTILITY(U,$J,358.3,10408,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10408,1,2,0)
 ;;=2^TB
 ;;^UTILITY(U,$J,358.3,10408,1,3,0)
 ;;=3^86580
 ;;^UTILITY(U,$J,358.3,10409,0)
 ;;=95024^^40^443^3^^^^1
 ;;^UTILITY(U,$J,358.3,10409,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10409,1,2,0)
 ;;=2^INTRADERMALS (EACH)
 ;;^UTILITY(U,$J,358.3,10409,1,3,0)
 ;;=3^95024
 ;;^UTILITY(U,$J,358.3,10410,0)
 ;;=86510^^40^443^2^^^^1
 ;;^UTILITY(U,$J,358.3,10410,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10410,1,2,0)
 ;;=2^HISTOPLASMOSIS
 ;;^UTILITY(U,$J,358.3,10410,1,3,0)
 ;;=3^86510
 ;;^UTILITY(U,$J,358.3,10411,0)
 ;;=99395^^40^444^1^^^^1
 ;;^UTILITY(U,$J,358.3,10411,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10411,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT 18-39
 ;;^UTILITY(U,$J,358.3,10411,1,3,0)
 ;;=3^99395
 ;;^UTILITY(U,$J,358.3,10412,0)
 ;;=99396^^40^444^2^^^^1
 ;;^UTILITY(U,$J,358.3,10412,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10412,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT 40-64
 ;;^UTILITY(U,$J,358.3,10412,1,3,0)
 ;;=3^99396
 ;;^UTILITY(U,$J,358.3,10413,0)
 ;;=99397^^40^444^3^^^^1
 ;;^UTILITY(U,$J,358.3,10413,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10413,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT > 64
 ;;^UTILITY(U,$J,358.3,10413,1,3,0)
 ;;=3^99397
 ;;^UTILITY(U,$J,358.3,10414,0)
 ;;=99385^^40^445^1^^^^1
 ;;^UTILITY(U,$J,358.3,10414,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10414,1,2,0)
 ;;=2^PREVENTIVE MED,NEW PT 18-39
 ;;^UTILITY(U,$J,358.3,10414,1,3,0)
 ;;=3^99385
 ;;^UTILITY(U,$J,358.3,10415,0)
 ;;=99386^^40^445^2^^^^1
 ;;^UTILITY(U,$J,358.3,10415,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10415,1,2,0)
 ;;=2^PREVENTIVE MED,NEW PT 40-64
 ;;^UTILITY(U,$J,358.3,10415,1,3,0)
 ;;=3^99386
 ;;^UTILITY(U,$J,358.3,10416,0)
 ;;=99387^^40^445^3^^^^1
 ;;^UTILITY(U,$J,358.3,10416,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10416,1,2,0)
 ;;=2^PREVENTIVE MED,NEW PT > 64
 ;;^UTILITY(U,$J,358.3,10416,1,3,0)
 ;;=3^99387
 ;;^UTILITY(U,$J,358.3,10417,0)
 ;;=99497^^40^446^1^^^^1
